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Nutritional and prognostic correlates of bioimpedance indexes in
hemodialysis patients. We carried out a cross sectional and longitudinal
study to assess whether bioimpedance indexes (resistance, Rz; reactance,
Xc; phase angle, PA) reflect the nutritional status of hemodialysis (HD)
patients, and bear a significant association with their long-term survival.
The bioimpedancc data of 131 patients on chronic HD treatment were
compared with those of 272 healthy controls matched for age and sex.
Nutritional status was assessed by anthropometric variables, serum albu-
min (SA), normalized protein catabolic rate (nPCR), and subjective global
assessment (SGA). All three hioimpedance indexes varied significantly
with HD treatment, however, with the exception of Xc in post-HD, they
were on average significantly (P < 0.016) different from controls either
pre- and post-HD. Post-HD PA appeared to be the best index of
nutritional status, being significantly correlated with SA, age, mid arm
muscle circumference (MAMC), SGA, and nPCR (R2 = 0.44; P < 0.01).
However, depending on the cut-off levels, PA failed to detect clinically
overt malnutrition in one to two thirds of the 12 patients with the worst
SGA score. During the follow-up the changes in bioimpedance indexes
reflected poorly the changes in dry body weight, only the Rz bore a
significant correlation (r = — 0.29; P < 0.01) with body wt. Patients
having baseline phase angle values within the lower quartile had a
significantly lower two-year survival rate than patients having higher
values (59.3% vs. 91.3%; P < 0.01). Cox's analysis (proportional hazard
model) showed that phase angle as a predictor of death outweighed all
other parameters included in the model (age, SA, nPCR, MAMC, SGA),
with a relative risk of 2.6(95% CI = 1.6 to 4.2). Bioimpedance indexes do
not appear to be reliable in detecting clinically Overt depletion of lean
body mass. However, the strong association of PA with patient survival
suggests that this bioimpedance index reflects some dimension of the
illness, which is not fully identifiable with the deranged nutritional status.
Bioimpedance analysis (BIA) is increasingly used for assessing
the nutritional status in sick patients, including those on chronic
hemodialysis (HD) treatment [1—5]. BIA relies on the measure-
ment of the voltage drop occurring when a constant, alternating
electrical current is applied to the living organism. The impedance
(Z) signal obtained from BIA is separated into two components,
resistance (Rz) and reactance (Xc), both measured in ohms. Rz
and Xc are used to estimate body composition by means of
empirical equations based on their correlations with validated
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reference methods. In these equations Rz is used to predict total
body water, and lean body mass (LBM) [6, 7]; the ratio Xc/Rz or
its geometrical derivative, phase angle (PA) is used to predict the
total body cell mass (BCM) [81.There are, however, some pitfalls
with the use of BIA equations. First, the equations contain other
variables beside the bioimpedance indexes, such as body weight,
height, and age, which by themselves can quite accurately predict
TBW in both healthy subjects and HD patients [9—111. Second,
the elaboration of bioimpedarice indexes into volume estimates
stems from the theory equating the human body to a homoge-
neous cylindrical conductor of the electrical current. In its appli-
cation to human beings BIA is, however, far removed from this
model, because the contribution of one arm and one leg to total
body Rz is disproportionately higher (90%) than that of the trunk
(10%), which represents nearly 50% of the body wt [12]. In
applying the standard BIA equations to sick patients, one has to
rely on the unproven assumptions that the disease states do not
alter neither the relative contributions of the various body seg-
ments to total Rz, nor the specific tissue resistance [13]. Due to
these drawbacks, studies in HD patients based on standard BIA
equations deserve reappraisal.
In this investigation we explored the clinical meaning of bioim-
pedance parameters without expanding them into volume esti-
mates. To this purpose we looked for their nutritional and
prognostic correlates in a fairly large population of patients on
chronic HD treatment. As nutritional correlates we chose the
parameters most commonly assessed in dialysis patients. As
prognostic correlate we chose the mortality rate recorded during
the follow-up.
Methods
Study populations
All hemodialysis outpatients receiving treatment for longer
than six months in three Hospital Dialysis Units were enrolled
into the study. One hundred thirty-one patients entered into the
study over the period of April 1991 to October 1992. All patients
were Caucasian, 65 were women, 36 had severe comorbid condi-
tions such as cancer [4], symptomatic peripheral vascular disease
[7], symptomatic cardiac disfunction [17], and chronic obstructive
pulmonary disease [81. On study entry, the mean age was 62.5±
(so) 13.6 years, and mean duration on dialysis treatment was 75
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58.6 months. The underlying renal diseases sustaining the termi-
nal uremic state were chronic glomerulonephritis in 29, chronic
interstitial nephritis in 21, hypertension in 18, polycystic kidney
disease in 20, diabetic nephropathy in 8, and other disorders in 35.
To get the normal values of bioimpedance indexes, we studied 272
healthy subjects matched for age and sex with the entire patient
population. They were recruited among hospital personnel and
healthy volunteers in the general population.
Dialysis prescription
All patients were on a thrice weekly HD regimen: 44 with
cellulosic membrane, 87 with noncellulosic membrane (63 high
flux, 24 low flux). High efficiency treatment with shortened dialysis
time (150 to 180 mm) and large surface dialyzers (1.8 to 2 m2)
were used in 44 patients, while the duration of dialysis time was
210 to 240 minutes in the remaining patients, whatever the
membrane used.
Study design
Upon enrollment, each patient underwent nutritional assess-
ment and bioimpedance measurements. Patients were then mon-
itored for up to 41 months. To assess whether the bioimpedance
indexes reflect the intra-individual changes in nutritional indexes
occurring over time, we repeated all the determinations after 6 to
12 months in all patients still available to follow-up. Clinical
outcomes monitored were death, transplantation, transferral to
other dialysis technics or to other Dialysis Centers.
Nutritional assessment
Clinical indexes of nutritional status were assessed concurrently
with BIA on the same midweek dialysis day. Assessment of
nutritional status was based on measurements of serum albumin
(SA) levels, anthropometric indexes, normalized protein catabolic
rate (nPCR), and subjective global assessment (SGA). To mini-
mize the variability among the Dialysis Units involved in this
investigation, chemical measurements were all made in the same
laboratory and the clinical assessments by a single physician.
Serum albumin was determined by laser immunonephelometry on
blood samples collected at the start of the hemodialysis session.
Anthropometric indexes were obtained at the end of the dialysis
treatment: upper arm circumference was measured on the non-
access limb with a tape with the arm hanging relaxed; triceps
skinfold was measured with a Lange skin-caliper. Mid arm muscle
circumference (MAMC) was derived from mid arm cicumference
(MAC) and triceps skinfold (TS), where MAMC = MAC — 3.14
* TS. Body mass index (BMI) was calculated as the ratio between
end-dialysis body weight in kg, and the square of height in nPCR
was calculated by the equation of Gotch and Sargent based on the
urea appearance rate [141. To determine the urea appearance
rate, we measured the increment of serum urea over the midweek
dialytic interval starting 30' after the end of the dialysis session, to
make an allowance of urea rebound, which in high efficiency
treatments may be higher than 20% [151. Total body water was
estimated by the equations of Watson et al [16]. SGA was based
on the method described by Detsky et al [17] with slight modifi-
cations. The subjective assessment was carried out by an investi-
gator (SN) who was blinded to the results of the other nutritional
tests. According to his judgment nutritional status was scored
either one (normal), two (moderately impaired), or three (severe-
ly impaired), based on the presence or absence of an history of
recent weight loss, anorexia and vomiting, and an estimate of
muscle wasting and loss of subcutaneous fat.
Bioimpedance indexes
Bioimpedance indexes were measured with a bioimpedance
instrument (BIA 101; Akern RJL Systems, Florence, Italy).
Measurements were made with the subjects lying in bed with the
arms and limbs abducted. Injection electrodes were placed over
the dorsum of the hand (contralateral to the access limb in dialysis
patients) in the midline, just proximal to the phalangeal-metacar-
pal joint, and over the dorsum of the homolateral foot just
proximal to the metatarso-phalangeal joint. The detection elec-
trodes were placed on the dorsum side of the hand midway
between the radial and ulnar styloids, and midway between the
malleoli of the leg. Adherence of electrodes to the skin was
insured through self adhesive tape. An excitation current of 800
micro Amp at fixed 50 kHz was introduced into the subjects at the
distal electrodes of the hand and foot, and the voltage drop was
detected by the proximal electodes. All measurements were taken
in triplicate, in HD patients they were obtained both before and
after the HD session. In preliminary crossover studies, we found
that post-HD bioimpedance indexes are not significantly affected
by the variations in serum electrolytes usually met with the various
treatment modalities used in this study, provided that the amount
of body fluid removed during each session was held unvaried.
Bioimpedance indexes are affected by body fluid removal [1, 1,
and it is known that immediately after the dialysis session
equilibration among body water compartments has not yet
reached the steady state. Therefore, to assess how stable are the
bioimpedance indexes shortly after the dialysis treatment, we
repeated the measurements after 90 minutes in 7 patients crossed
over through the various dialysis modalities used in the population
study. Xc and PA did not vary significantly during this interval,
while Rz decreased by 10 ohms only, from 614 33 to 604 36
(P < 0.01 by paired t-test). To minimize the cyclical variations in
bioimpedance indexes due to changes in hydration state of the
patients, we based our analysis on values obtained at the end of
HD treatment. The coefficient of variation between paired
post-HD measurements performed two weeks apart on 18 pa-
tients were 5.3% for Rz, 7.5% for Xc, 7% for PA.
Statistical methods
We used the paired and unpaired two-tailed Student's t-tests (P
values significant if less than 0.05) with the Bonferroni correction
for multiple comparisons. To assess the strength of associations
between variables, we used Pearson's correlation r, or Spearman
rank correlation coefficient for selected analyses. Stepwise multi-
ple regression analyses were carried out with the help of a
statistical software (Statgraphics, version 4). Survival was com-
puted by the Kaplan-Meier method and the difference between
survival curves by the Mantel-Haenszel (log-rank) statistics. We
examined the independent relationship to mortality risk of bio-
impedance indexes and nutritional variables using a proportional
hazard regression model (BMDP program P2L, Dept. of Bio-
mathematics, University of California, Los Angeles, 1990) based
on the data recorded on initial enrollment. By a stepwise selection
process, variables were entered or removed from the regression
equation on the basis of the maximized partial likehood ratio.
Nutritional and bioimpedance indexes were treated as categorical
variables with breakpoints corresponding to the quartile cut-offs
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Table 1. Bioelectric indexes in controls and HD patients
Controls HD patients
M/F
Age years
Height cm
Body wt kg
R ohms
X ohms
PA rad
136/1 36
61.6 (14.5)
162 (10.3)
66.8 (11.8)
535 (73)
56.3 (10.1)
6.0 (.9)
65/66
62.5 (13.6)
161 (9.7)
pre-HD post-HD
63.7 (12.4y 61.4 (12.2)ah
565 (98) 656 (115)'
41.5 (10.2)a 58.6 (14.8)
4.2 (1.0)' 5.1 (13)ah
Data are mean (± 1 SD).
a P  0.016, no superscript denotes P > 0.016 in the comparisons
between patients (pre-HD and post-HD values) and controls by the
Bonferroni t-test
h P< 0.01 in comparison between pre-HD and post-HD values (paired
t-test)
in the HD population. The relative risk for each independent
variable was expressed as the exponential of the coefficient of the
variable in the hazard equation.
Results
Bioimpedance indexes in controls and HD patients
The bioimpedancc data obtained in controls and HD patients at
the baseline examination are shown in Table 1. Before starting the
HD treatment the patients had higher Rz (P < 0.016), and lower
Xc and PA (P < 0.016 for both indexes) than normal controls. HD
treatment caused an increase in all three bioimpedance indexes,
but brought to normal only Xc, while Rz increased further above
the normal values, and PA remained still significantly below them.
The changes in bioimpedance indexes (difference between
pre-HD and post-HD values) were inversely related to the
amounts of body fluid removed during the HD session, with
Pearson's r values of —0.39 (P < 0.01) for Rz, —0.48 (P < 0.01)
for Xc, and —0.36 (P < 0.01) for PA.
Relationships between bioimpedance and nutritional indexes
The r values of the simple correlations between the post-HD
bioimpedance parameters and nutritional indexes, including age,
are shown in Table 2. Rz appeared to reflect the anthropometric
characteristics of the patients better than the two other bioelectric
indexes, especially MAMC. PA correlated significantly with all
nutritional indexes except BMI. Stepwise regression analysis was
performed to determine which of the variables listed in Table 2
were independent predictors of bioimpedance indexes. Significant
(P < 0.01) predictors were MAMC and SGA for Rz (R2 = 0.41);
age, SA, and nPCR for Xc (R2 = 0.28); SA, age, MAMC, SGA,
and nPCR for PA (R2 0.44). Table 3 shows the relationships
between PA and nutritional indexes in patients subdivided accord-
ing to the lower quartile, interquartile and upper quartile of PA
values adjusted for sex. The lower quartile patients were on
average older and had most nutritional indexes significantly more
deranged than those belonging to the upper quartile, while they
differed from those in the interquartile range for BMI, SA, and
nPCR. Table 4 shows the relationship between SGA and PA
quartiles. Limiting the analysis to the lower PA quartile, this
included 8 of the 12 patients scored SGA three (sensitivity =
67%), and 26 of the 119 patients scored SGA one or two
(specificity = 78%). If the cutoff limits of PA are lowered to the
tenth percentile, the specificity increases to 91%, but the sensitiv-
ity drops to 33%. The diagnostic yields of Rz or Xc were even
lower than that of PA (data not shown).
Changes in bioiinpedance and nutritional indexes during follow-up
A repeat examination was carried out after 7.4 1.9 months on
118 patients. On this occasion, the correlation levels between
bioimpedance and nutritional indexes were very close to those
recorded at baseline (data not shown). Noteworthy is the fact that
nearly 80% of patients having PA values within the lower quartile
at the baseline evaluation were still in this category at the repeat
examination, which now included a further 12 patients previously
belonging mostly to the interquartile range (Table 5). The intra-
individual variations in nutritional indexes recorded at the repeat
examination were on average of modest degree, but their ranges
were considerably wide (Table 6). The changes in nutritional
indexes that were significantly correlated with the changes in
bioimpedance indexes were the following: body wt with Rz
only (r = —0.29; P < 0.01), MAC with Xc (r = 0.26; P = 0.01)
and zPA (r = 0.31; P < 0.01), LnPCR with zXc (r = 0.19; P <
0.05) and ZPA (r = 0.20; P < 0.05).
Prognostic value of bioimpedance indexes
During the follow-up lasting 26.6 8.9 months, 23 patients
died, 6 had renal transplants and 3 were transferred to other
dialysis Centers or began peritoneal dialysis treatment. Causes of
death were cachexia in 4, infectious complications in 6, cerebro-
vascular accidents in 3, cardiovascular complications in 3, gastro-
intestinal hemorrage in 2, and other accidents in 5. Most deaths
(15 out of 23) occurred in patients having phase angle values
within the lower quartile at baseline. The actuarial survival curves
for patients having baseline PA values above and below the 25th
percentile are shown in Figure 1. The difference between the two
survival curves is highly significant (P < 0.01), the probability of
surviving longer than 24 months being 91.3% and 5 1.3%, respec-
tively. A Cox proportional hazard analysis was done to determine
how PA compared with other nutritional variables in the predic-
tive power of long-term survival of patients. The covariates
examined were age, PA, MAMC, nPCR, SA, scored 1 to 4
according to the quartile cutoffs (score 4 for lower quartile, score
1 for upper quartile of all variables, except age, which was scored
in the opposite way), and SGA scores (Table 7). Significant risk
predictors of death were PA, SGA, age, and SA (Table 8).
However, the stepwise procedure selected PA as the only signif-
icant predictor (ehi square = 17.8; P = 0.000), having a beta
coefficient of 0.94 SE 0.26 (relative risk of death 2,6; 95% CI,
range 1.6 to 4.2).
Discussion
In this investigation we found that HD patients had on average
significantly different bioimpedance data from those of control
population. As previously found by others [1, 4], bioimpedance
indexes varied with dialysis treatment in relation to the body fluid
removal, but their changes did not reflect accurately the changes
in body wt, as shown by r2 values of 0.23 or less. The removal of
fluid excess notwithstanding, two bioelectrical indexes, namely Rz
and PA, remained significantly different from normal at the end of
diaysis treatment. These abnormalities could be partially ac-
counted for by the deranged nutritional status of HD patients. In
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Table 2. r values for simple correlations between bioelectrical indexes and other variables in HD patients
Age Body wt BMI MAC MAMC nPCR SA SGA
R 0.05 0.48a 0.38a 0.62 —0.19 —0.18 0.29a
X 0.45a —0.12 —0.14 0.003 —0.09 0.35a 0.34a 0.21
PA 0.42a 0.25a 0.10 o.29a 0.36a 0.22a 0.46a 0.43a
All r values are Pearson's correlation coefficients except those reported in the SGA column, which are Spearman's rank correlation coefficients.
P 0.01; no superscript denotes P > 0.05
A
Lower quartile
N=34
B
InterquartileN=68
C
Upper quartileN=29
Age years
Body wt kg
BMI kg/rn2
67.1 (12.3)
57.7 (10.6)
22.1 (3.3)
64.8 (11.0)
61.5 (12.5)
23.9 (3.8)a
51.6 (15.1)
66.4 (12.i)'
24.4 (3.8)h
MAC cm
MAMC cm
26.5 (3.5)
20.0 (2.7)
28.1 (2.1)
21.2 (2.3)
29.7 (3.5)'
22.3 (2.5)'
nPCR
SA g/dl
.90 (.26)
3.25 (.63)
1.04 (.26)a
3.58 (.38)a
1.01 (.22)
3.84 (.42)
Values are expressed as means (± 1 su).
Superscripts denote significant differences by the Bonferroni t-test (P
0.016).
a Group B vs. Group A
b Group C vs. Group A
C Group C vs. Group B
No superscript denotes P> 0.016
SGA score
PA quartiles
Lower quartile Interquartile Upper quartile
One 12 53 25
Two 14 11 4
Three 8 4 0
Table 5. Changes in patient distribution among PA quartiles during
follow-up
Baseline
Follow-up
Lower quartile Interquartile Upper quartile
Lower quartile 23 6 0
Interquartile 11 41 9
Upper quartile 1 8 19
fact, we found significant correlations between post-HD bioim-
pedance indexes and the clinical-laboratory indexes of nutritional
status, especially between PA and indexes of body protein deple-
tion. PA appeared to more comprehensively epitomize the pa-
tients' nutritional status than Rz or Xc, being correlated with SA,
age, MAMC, SGA, and nPCR, which together accounted for 44%
of its variance. Overall, our results denote a trend for bioimped-
ance parameters to reflect the nutritional status of HD patients,
and agree with previous studies [18—21] showing that these
indexes, especially PA, tend to be altered in severe malnutrition
due to various disease states.
We noted, however, important limitations regarding the reli-
Variables X so Range
Body wt kg —0.9 2.8 —10.6 6.9
z R ohms 6.0 56.3 —189 179
XC ohms —2.7 11.8 —37 32
PA rad —0.26 0.86 —2.9 1.9
MACcm —0.2 1.4 —5.0 4.0
MAMC cm —0.17 1.7 —5.5 4.3
nPCRg/kg/day —0.02 0.23 —0.71 0.79
SAg/dl —0.01 0.53 —2.0 1.0
SD and range, between
ability of bioimpedance parameters as nutritional indexes, First,
depending on the cut-off value chosen, PA failed to reflect the
overt malnourished state in one third to two thirds of the 12
patients who scored 3 SGA. Results with the other two bioimped-
ance indexes were even worse. In our opinion, the failure to
reflect a clinically obvious muscle wasting, even if only in a small
patient sample, speaks against the validity of bioimpedance
parameters for nutritional assessment. Second, the changes in the
bioimpedance indexes that were detected several months after the
baseline examination correlated poorly (the Rz) or not at all (Xc
and PA) with the changes in dry body wt, which in several patients
Table 3. Relationships between nutritional indexes and phase angle
quartiles in HD patients
Table 6. Changes in nutritional and bioelectrical indexes during
follow-up
Table 4. Relationship between SGA scores and PA quartiles
Data represent the number of patients.
Values express the mean difference, with
baseline and follow-up determinations
100.0
91.3% A
80.0
60.0 .593% B
>
40.0
20.0
0.0
0.0 4.0 8.0 12.0 16.0 20.0 24.0
Time, months
Fig. 1. Survival curves (Kaplan-Meier estimate) in patients having PA values
above (curve A) and below (curve B) the 25th percentile at the baseline.
Vertical bars represent the 95% confidence intervals. The difference
between the two survival curves is highly significant. P < 0.01 by the
log-rank test.
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Table 7. Quartile cutoffs of variables entered into the Cox model
Percentiles 25 50 75
Age years 55 66 73
SAg/dl 3.3 3.6 3.9
nPCRg/kg/day 0.82 0.96 1.15
MAMC cm MF
20.7
18.4
22.7
19.7
24.0
21.6
PA rad MF
4.5
4.2
5.2
4.8
6.2
5.4
were so large as to bring about a clinically evident reduction in
muscular mass. This observation agrees with previous studies in
nonuremic individuals [22, 231. Forbes, Simon and Amatruda [22]
reviewed seven studies of adults undergoing changes in body
weight due to diet plus exercise. Only two of these studies showed
significant correlations between the changes in LBM, assessed by
independent methods, and the changes in Rz. By contrast, five of
the seven studies showed a significant relationship between the
changes in LBM and changes in body weight. The authors
concluded that "body wt change appears to be more reliable
predictor of LBM change than is change in body resistance."
On the other hand, our findings seem to disagree with the
results of a recent study on HD patients [3], but a close scrutiny of
the data show that the discrepancies are more apparent than real.
In this study, Chertow et al found in HD patients a high
correlation (r = 0.92) between BCM derived from BIA and that
estimated by the reference method (dual-energy X-ray absorpti-
ometry and NaBr space). However, the differences between the
results of the two methods had such wide a range, from 0 to nearly
—15 kg, as to make uncertain the validity of the BIA estimates.
Moreover, they failed to find significant correlations between the
BIA estimates and most nutritional indexes in their population
sample, which was considerably smaller than ours.
The limitations outlined above might be overcome with the use
of the multi-frequency BIA (MFBIA), which is becoming increas-
ingly popular. Because at low frequency the electrical current
passes predominantly through extracellular fluids, while at higher
frequency it can penetrate the cell membrane and thus pass
through both intracellular and extracellular fluid, MFBIA could
provide more accurate estimates than the single-frequency BIA of
the extracellular water and total body water [24], and hence a
more reliable index of the nutritional status [6]. However, a recent
study on surgical patients failed to show any significant improve-
ment of MFBIA over BIA when both methods were matched with
the reference radioisotopic methods used to assess total body
water and extracellular water [25]. The authors attributed the
failure of MFBIA to reduce the error of the estimates to the
difficulties inherent in the theory assuming the human body as
homogeneous conductor of the electrical current. Should this be
the case, one might overcome these problems by performing
segmental body measurements. Pending such studies, the data at
hand suggest that bioimpedance measurements can provide, at
most, a generic index of health derangement in HD patients, and
as such are only indirectly related to the nutritional status. In this
regard, the clinical implications of the PA resemble that of the
SA. Even though neither index can be considered a specific
marker of lean body mass depletion [26], each tends to reflect the
severity of the patient's "sickness." Therefore, it is usual to find
Table 8. Independent predictors of death in 131 HD patients in the
multivariate regression model
,2 P value
Age 5.67 0.017
PA 17.77 0.0000
MAMC 1.37 0.24
SA 3.95 0.047
SGA 11.14 0.0008
nPCR 3.2 0.074
that both are deranged in the more compromised patients, as we
did in the cross sectional assessment. However, since they express
quite different aspects of the disease process, it comes as no
surprise that they follow independent courses over the follow-up
period, as we observed in the longitudinal assessment.
The growing importance of nutritional assessment in the man-
agement of dialysis patients stems from observations showing that
several nutritional indexes are significantly associated with patient
survival [27—29]. Therefore, the appraisal of a new nutritional
index should include the assessment of its prognostic bearings. We
did so, and found that, notwithstanding its limited value as a
nutritional index, PA was significantly associated with survival. In
fact, patients having PA values within the lower quartile at
baseline showed a much lower two-year survival rate (5 1.3%) than
those having higher values (91.3%). It appears unlikely that this is
a fortuitous association due to fleeting abnormalities of PA
detected at the moment of baseline determinations, because most
patients categorized in the lower PA quartile at baseline were still
within this category several months later. Moreover, the shorter
survival of these patients is not an unexpected result, because at
baseline they showed worse prognostic markers than those in the
upper quartiles. Indeed, the Cox analysis showed that PA was
associated with survival more strongly than age or nutritional
indexes previously shown to be endowed with prognostic power
[27—29]. The prognostic importance of PA is supported also by a
recent study in AIDS patients [30] where this index was found to
be a more powerful predictor of their long-term survival than the
usual nutritional indexes. It is difficult to provide a plausible
explanation for these empirical observations, because the biolog-
ical meaning of PA is not yet fully understood. Some authors
believe that PA might reflect derangements in the electrical
charges of cell membranes, which are often associated to an
altered water partitioning between the intracellular and extracel-
lular compartment [30—31], but direct evidence supporting this
interpretation is lacking. Whatever the mechanism, these obser-
vations suggest that PA reflects some dimension of the illness that
is not fully identifiable with the deranged nutritional status, which
must be important for the prognosis. Obviously, these results need
to be confirmed on larger patient populations before being
accepted as conclusive. Moreover, further studies are required to
clarify the biological meaning of the bioelectrical indexes in order
to better understand their abnormalities in disease states.
In conclusion, compared with normal population a substantial
proportion of HD patients showed marked changes in bioimped-
ance indexes. These indexes appeared to be little reliable in
detecting the gross changes in lean body mass. However, com-
pared with the usual nutritional parameters, PA appeared to be a
better prognostic index of patient mortality. Our and analogous
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observations reported by others suggest that PA reflects some as
yet unknown biologic properties, of which the nutritional status is
but one expression.
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